本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Alterity Therapeutics Limited

3.34
-0.0845-2.47%
成交量:1.45萬
成交額:4.85萬
市值:6,045.82萬
市盈率:-4.47
高:3.40
開:3.39
低:3.33
收:3.42
52周最高:7.00
52周最低:2.04
股本:1,812.57萬
流通股本:1,245.82萬
量比:1.61
換手率:0.12%
股息:- -
股息率:- -
每股收益(TTM):-0.7470
每股收益(LYR):-0.7470
淨資產收益率:-43.23%
總資產收益率:-28.09%
市淨率:2.14
市盈率(LYR):-4.47

資料載入中...

2025/08/29

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/09/26

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/08/31

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/10/31

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/31

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/08/26

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/01

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/21

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/28

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/04

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/07/08

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/04

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/02

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/11/25

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/19

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/26

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/10/08

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/23

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/09/15

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/07/06

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership